Shenguan Holdings (Group) Limited
SHGXY
Other OTC0.45
USD
- -
- -
ISIN
US82321V1017
CUSIP
82321V101
Return %
Stock
S&P500
1Y
-32.73
26.53
3Y
-53.57
76.60
5Y
-48.22
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Yaxian Zhou
- Full Time Employees
- 3,070
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- Sino Plaza Causeway Bay Hong Kong
- IPO Date
- Apr 2, 2012
- Website
- shenguan.com.hk
- Similar Companies
- Business
- Shenguan Holdings (Group) Limited, incorporated in the Cayman Islands in 2009 and listed on the Hong Kong Stock Exchange (stock code: 0829), is an investment holding company principally engaged in the manufacture and sale of edible collagen sausage casings under the Shenguan brand; collagen food products including ready-to-eat beef tendon, collagen brown sugar ginger drink, collagen oat drinks, collagen oat porridge, Bo Bo Chicken and Beef Tripe; collagen skincare products such as masks, skin nourishing lotions and multi-effective gel creams under brands including Luxianna, COLL-FULL, Collagen Family and coll-shine; and polymer collagen medical biomaterials encompassing medical collagen raw materials, collagen bone filling biomaterials (artificial bone), dental medical collagen sponge, oral post-operative medical collagen sponge, medical collagen dressing and small beauty needle. The group, with main production facilities in Wuzhou, Guangxi Province in Mainland China and headquarters in Causeway Bay, Hong Kong, pioneered the first collagen sausage casings in China in 1989 and holds three world-first core technologies along with multiple invention patents; it serves leading meat processors and sausage manufacturers primarily in Mainland China (over 85% of revenue), Asia excluding Mainland China and other regions including Southeast Asia, Europe, South America and the United States, with operations certified under ISO9001, ISO22000, ISO14001 and Halal standards, and registered with the US FDA for exports. In recent developments, the group launched six new high-end collagen sausage casing series—fried, crispy, fresh, tender, bright and colorful—accounting for about 40% of sausage casing sales in the first half of 2025 interim period while expanding production capacity to 7 billion meters annually through technological upgrades and facility renovations; non-sausage casing segments including collagen food, skincare and medical biomaterials saw sales growth of 93% in 2025 interim versus prior year and 83% for full-year 2024, driven by new product introductions, promising medical collagen raw material sales up 543% in 2024 with endotoxin levels exceeding FDA standards at 0.01EU/ml, advancing Class III medical device registrations, clinical trials for dental sponges and ongoing R&D collaborations with Huazhong University of Science and Technology yielding patents in sound-absorbing materials and food packaging; the group also achieved 2025 interim results release on August 25 and 2024 annual results announcement on March 24, 2025, with revenue of RMB1.02 billion and profit attributable to owners of RMB26.7 million for 2024 amid product upgrades and cost efficiencies improving gross margins to 16.8%.